Lundbeck corporate website: partial takedown altered a certified site (AUTH/3466/2/21)

📅 2021 | 🖉 Dr Anzal Qurbain
📊

Key facts

CaseAUTH/3466/2/21
CompanyLundbeck Limited
MaterialLundbeck UK corporate website (microsite within Lundbeck.com domain)
ComplainantAnonymous, contactable; described as a health professional
Complaint received01 February 2021
Case completed27 September 2021
Applicable Code year2019
AppealNo appeal
Breach clauses9.1, 14.3
No breach clauses2, 14.1, 28.1
SanctionsUndertaking received; additional sanctions not stated
Key issueUnpublishing a single page altered a website certified in its entirety, without re-certification

Download the full case report (PDF)


Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory

🤖

Got a question about this case?

Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.

Ask AskAnzal AI
🎬 Expert Video Walkthrough
🎬
Video walkthrough — coming for members
Subscribe now and get expert video analysis for every case as we publish them.
Subscribe — from £299/yr
📋

What happened

  • An anonymous, contactable complainant (self-described health professional) complained about Lundbeck Limited’s UK corporate website and referenced a prior complaint about similar material (Case AUTH/3463/1/21).
  • The complainant alleged the “About us” page was inappropriate for the public/patients and had not been re-approved since 2018 (job number UK-NOTPR-0031 shown on pages).
  • The complainant alleged the “About us” page linked to a UK “research and development” page, which then linked out to the global site where the complainant said pipeline/products information could be found.
  • Lundbeck said it intended to take down the UK website in its entirety in January 2021 to determine whether reapproval was needed; the home page was unpublished but, due to human error, other pages remained live until 1 February 2021.
  • Lundbeck said the UK site had been certified as a whole on 7 December 2018 and included a pop-up warning users they were being redirected to a non-UK website; global pages were clearly marked “GLOBAL”.
  • The Panel noted the complainant’s link to the “About us” page was not available when accessed by the case preparation manager (the remaining pages had been taken down on 1 February 2021, before the complaint was received on 4 February 2021).
⚖️

Outcome

  • Breach found: Clause 14.3 and Clause 9.1.
  • No breach: Clauses 2, 14.1 and 28.1 (and no breach of 14.3 in relation to initial certification date).
  • The Panel ruled that unpublishing a single page of a website that had been certified in its entirety altered the final form of the website without re-certification (breach of Clause 14.3).
  • Because robust certification underpins self-regulation, the Panel ruled high standards had not been maintained (breach of Clause 9.1).
  • The Panel did not consider the circumstances warranted Clause 2 (no breach of Clause 2).
🔒

Unlock the full case analysis

Members get the complete breakdown — Clauses, Sanction, Signatory Lens, Audit checklist, and 3 Key Questions.

Best value
£249/year
Annual — save £99
or
£29/mo
Monthly
Join Now — Instant Access

⭐ Business Intelligence Access

See the full compliance picture for every pharma company

291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.

Request Access →
⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week — free.

Subscribe Free
🎓 AQP Training